Samuel Andrade Farias Alves
Samuel Andrade Farias Alves has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Diego dos Passos Santiago4 shared publications
- Anaísa Filmiano Andrade Lopes
Mestranda em Arquitetura e Urbanismo UFU Brasil
3 shared publications - Camille Silva Nogueira
Graduanda em Medicina Instituição Afya Faculdade de Ciências Médicas Itabuna Endereço: Av. Ibicaraí 3270 Nova Itabuna Itabuna -BA Brasil
2 shared publications - Dimitri Mota Barros2 shared publications
Diogo Mariano Hildefonso
Graduating Medicine Centro Universitário São Lucas
2 shared publications- Emmanuelly Martins Guedes2 shared publications
Latest Publications
- Open Access
- 4 May 2025
- Published by Brazilian Journals in Contribuciones A Las Ciencias Sociales
- Vol. 18 (5) , e17817
Eficácia de implantes biodegradáveis vs. metálicos na fixação de fraturas do tornozelo: revisão dos desfechos biomecânicos e clínicos
Os implantes metálicos têm sido amplamente utilizados na fixação de fraturas ortopédicas devido à sua resistência e estabilidade, porém complicações como a necessidade de reoperações para remoção, interferência em exames de imagem e desconforto prolongado têm impulsionado o desenvolvimento de alternativas mais biocompatíveis. Nesse cenário, os implantes biodegradáveis, como os de PLGA e ligas de magnésio, surgem como tecnologias promissoras por se degradarem progressivamente no organismo, eliminando a necessidade de remoção cirúrgica. Este estudo teve como objetivo comparar a eficácia e segurança dos implantes biodegradáveis em relação aos metálicos na fixação de fraturas do tornozelo, com extensão a outras localizações articulares e ósseas de interesse clínico. Foi realizada uma revisão narrativa da literatura, com busca nas bases PubMed, Embase, Scopus, Web of Science e Cochrane Library, considerando publicações entre 2017 e 2024. Foram incluídos 15 estudos clínicos e experimentais que abordaram aspectos como eficácia funcional, taxa de reoperação, complicações, desempenho biomecânico e compatibilidade com exames de imagem. Os resultados demonstram que os implantes biodegradáveis apresentam desempenho clínico semelhante aos metálicos, com vantagens relevantes como menor taxa de reoperações, menor resposta inflamatória e menor interferência em exames de imagem, especialmente em pacientes pediátricos e fraturas articulares. Conclui-se que os implantes biodegradáveis são uma alternativa viável, segura e cada vez mais indicada, à medida que novos materiais com maior resistência e reabsorção controlada são desenvolvidos.
- 4 May 2025
- Published by Brazilian Journals in Contribuciones A Las Ciencias Sociales
- Vol. 18 (5) , e17817
Open AccessEficácia de implantes biodegradáveis vs. metálicos na fixação de fraturas do tornozelo: revisão dos desfechos biomecânicos e clínicos
Os implantes metálicos têm sido amplamente utilizados na fixação de fraturas ortopédicas devido à sua resistência e estabilidade, porém complicações como a necessidade de reoperações para remoção, interferência em exames de imagem e desconforto prolongado têm impulsionado o desenvolvimento de alternativas mais biocompatíveis. Nesse cenário, os implantes biodegradáveis, como os de PLGA e ligas de magnésio, surgem como tecnologias promissoras por se degradarem progressivamente no organismo, eliminando a necessidade de remoção cirúrgica. Este estudo teve como objetivo comparar a eficácia e segurança dos implantes biodegradáveis em relação aos metálicos na fixação de fraturas do tornozelo, com extensão a outras localizações articulares e ósseas de interesse clínico. Foi realizada uma revisão narrativa da literatura, com busca nas bases PubMed, Embase, Scopus, Web of Science e Cochrane Library, considerando publicações entre 2017 e 2024. Foram incluídos 15 estudos clínicos e experimentais que abordaram aspectos como eficácia funcional, taxa de reoperação, complicações, desempenho biomecânico e compatibilidade com exames de imagem. Os resultados demonstram que os implantes biodegradáveis apresentam desempenho clínico semelhante aos metálicos, com vantagens relevantes como menor taxa de reoperações, menor resposta inflamatória e menor interferência em exames de imagem, especialmente em pacientes pediátricos e fraturas articulares. Conclui-se que os implantes biodegradáveis são uma alternativa viável, segura e cada vez mais indicada, à medida que novos materiais com maior resistência e reabsorção controlada são desenvolvidos.
- Open Access
- 6 February 2025
- Published by RGSA- Revista de Gestao Social e Ambiental in Revista de Gestão Social e Ambiental
- Vol. 19 (2) , e011369
Systematic-Quantitative Analysis of Dapsone Treatment in Patients With Refractory Herpes Gestationis: Impact on Pregnancy Progression and Neonatal Outcomes
Objective: This study aims to systematically and quantitatively analyze the impact of dapsone treatment in patients with refractory herpes gestationis (HG), focusing on its effectiveness in improving pregnancy outcomes and neonatal health. Theoretical Framework: Herpes gestationis is a rare autoimmune blistering disorder that poses significant challenges in pregnancy management. While systemic corticosteroids remain the standard treatment, refractory cases necessitate alternative therapeutic approaches. Dapsone, known for its anti-inflammatory and immunomodulatory properties, has shown potential in achieving disease control in corticosteroid-resistant HG cases. Method: A systematic review was conducted by searching PubMed, Scopus, and Web of Science databases for studies published between 2016 and 2023. The inclusion criteria comprised studies that provided data on maternal and neonatal outcomes following dapsone treatment for refractory HG. Exclusion criteria eliminated studies with insufficient outcome reporting, unrelated conditions, and small sample sizes. Results and Discussion: The review identified promising outcomes associated with dapsone use in refractory HG, demonstrating symptom relief and improved maternal health. However, potential adverse effects, such as hemolysis and methemoglobinemia, necessitate careful monitoring. The findings emphasize the importance of individualized treatment strategies and multidisciplinary care to optimize outcomes. Research Implications: This study underscores the need for standardized protocols and large-scale clinical trials to establish the safety and efficacy of dapsone in pregnant women with HG. Further research should explore long-term neonatal health outcomes and refine treatment guidelines. Originality/Value: This review contributes to the limited literature on dapsone use in pregnancy, offering insights into its potential role as a second-line treatment in refractory HG cases and guiding future clinical practices.
- 6 February 2025
- Published by RGSA- Revista de Gestao Social e Ambiental in Revista de Gestão Social e Ambiental
- Vol. 19 (2) , e011369
Open AccessSystematic-Quantitative Analysis of Dapsone Treatment in Patients With Refractory Herpes Gestationis: Impact on Pregnancy Progression and Neonatal Outcomes
Objective: This study aims to systematically and quantitatively analyze the impact of dapsone treatment in patients with refractory herpes gestationis (HG), focusing on its effectiveness in improving pregnancy outcomes and neonatal health. Theoretical Framework: Herpes gestationis is a rare autoimmune blistering disorder that poses significant challenges in pregnancy management. While systemic corticosteroids remain the standard treatment, refractory cases necessitate alternative therapeutic approaches. Dapsone, known for its anti-inflammatory and immunomodulatory properties, has shown potential in achieving disease control in corticosteroid-resistant HG cases. Method: A systematic review was conducted by searching PubMed, Scopus, and Web of Science databases for studies published between 2016 and 2023. The inclusion criteria comprised studies that provided data on maternal and neonatal outcomes following dapsone treatment for refractory HG. Exclusion criteria eliminated studies with insufficient outcome reporting, unrelated conditions, and small sample sizes. Results and Discussion: The review identified promising outcomes associated with dapsone use in refractory HG, demonstrating symptom relief and improved maternal health. However, potential adverse effects, such as hemolysis and methemoglobinemia, necessitate careful monitoring. The findings emphasize the importance of individualized treatment strategies and multidisciplinary care to optimize outcomes. Research Implications: This study underscores the need for standardized protocols and large-scale clinical trials to establish the safety and efficacy of dapsone in pregnant women with HG. Further research should explore long-term neonatal health outcomes and refine treatment guidelines. Originality/Value: This review contributes to the limited literature on dapsone use in pregnancy, offering insights into its potential role as a second-line treatment in refractory HG cases and guiding future clinical practices.
- Open Access
- 24 January 2025
- Published by Seven Events
TECHNICAL ANALYSIS OF HARTMANN’S RETROSIGMOIDECTOMY IN THE EMERGENCY CONTEXT OF COMPLICATED DIVERTICULITIS HINCHEY III AND IV
Hartmann’s retrosigmoidectomy is a widely adopted surgical procedure for managing patients with complicated diverticulitis, particularly in Hinchey III and IV stages. These advanced stages are associated with high morbidity and mortality due to purulent or fecal peritonitis, necessitating emergent surgical interventions. This study presents a systematic technical analysis of Hartmann’s procedure in this emergency context, focusing on outcomes such as mortality, morbidity, stoma reversal rates, and long-term complications. A comprehensive search was conducted in PubMed, Embase, Cochrane Library, and Scopus for studies published between 2016 and 2024, using keywords like "Hartmann’s Procedure," "Complicated Diverticulitis," "Hinchey III and IV," and "Emergency Surgery." Of 34 initially identified studies, 10 met the inclusion criteria. Findings reveal that while Hartmann’s procedure remains a vital option for hemodynamically unstable patients, its limitations, such as low stoma reversal rates (43.9%, Facile et al., 2020) and higher long-term complication rates, underscore the need for patient stratification. Comparatively, primary anastomosis demonstrated superior outcomes in selected stable patients, with higher stoma reversal rates (86.9%, Bridoux et al., 2017) and improved quality of life. Advances in laparoscopic approaches have also shown potential in enhancing outcomes for Hartmann’s procedure. Despite its established role, the procedure’s high morbidity and low reversal rates prompt the need for further research into individualized patient selection and innovative surgical techniques.
- 24 January 2025
- Published by Seven Events
Open AccessTECHNICAL ANALYSIS OF HARTMANN’S RETROSIGMOIDECTOMY IN THE EMERGENCY CONTEXT OF COMPLICATED DIVERTICULITIS HINCHEY III AND IV
Hartmann’s retrosigmoidectomy is a widely adopted surgical procedure for managing patients with complicated diverticulitis, particularly in Hinchey III and IV stages. These advanced stages are associated with high morbidity and mortality due to purulent or fecal peritonitis, necessitating emergent surgical interventions. This study presents a systematic technical analysis of Hartmann’s procedure in this emergency context, focusing on outcomes such as mortality, morbidity, stoma reversal rates, and long-term complications. A comprehensive search was conducted in PubMed, Embase, Cochrane Library, and Scopus for studies published between 2016 and 2024, using keywords like "Hartmann’s Procedure," "Complicated Diverticulitis," "Hinchey III and IV," and "Emergency Surgery." Of 34 initially identified studies, 10 met the inclusion criteria. Findings reveal that while Hartmann’s procedure remains a vital option for hemodynamically unstable patients, its limitations, such as low stoma reversal rates (43.9%, Facile et al., 2020) and higher long-term complication rates, underscore the need for patient stratification. Comparatively, primary anastomosis demonstrated superior outcomes in selected stable patients, with higher stoma reversal rates (86.9%, Bridoux et al., 2017) and improved quality of life. Advances in laparoscopic approaches have also shown potential in enhancing outcomes for Hartmann’s procedure. Despite its established role, the procedure’s high morbidity and low reversal rates prompt the need for further research into individualized patient selection and innovative surgical techniques.
- Open Access
- 1 January 2025
- Published by Seven Events in ARACÊ
- Vol. 7 (1) , 2683-2696
TECHNICAL ANALYSIS OF HARTMANN’S RETROSIGMOIDECTOMY IN THE EMERGENCY CONTEXT OF COMPLICATED DIVERTICULITIS HINCHEY III AND IV
Hartmann’s retrosigmoidectomy is a widely adopted surgical procedure for managing patients with complicated diverticulitis, particularly in Hinchey III and IV stages. These advanced stages are associated with high morbidity and mortality due to purulent or fecal peritonitis, necessitating emergent surgical interventions. This study presents a systematic technical analysis of Hartmann’s procedure in this emergency context, focusing on outcomes such as mortality, morbidity, stoma reversal rates, and long-term complications. A comprehensive search was conducted in PubMed, Embase, Cochrane Library, and Scopus for studies published between 2016 and 2024, using keywords like "Hartmann’s Procedure," "Complicated Diverticulitis," "Hinchey III and IV," and "Emergency Surgery." Of 34 initially identified studies, 10 met the inclusion criteria. Findings reveal that while Hartmann’s procedure remains a vital option for hemodynamically unstable patients, its limitations, such as low stoma reversal rates (43.9%, Facile et al., 2020) and higher long-term complication rates, underscore the need for patient stratification. Comparatively, primary anastomosis demonstrated superior outcomes in selected stable patients, with higher stoma reversal rates (86.9%, Bridoux et al., 2017) and improved quality of life. Advances in laparoscopic approaches have also shown potential in enhancing outcomes for Hartmann’s procedure. Despite its established role, the procedure’s high morbidity and low reversal rates prompt the need for further research into individualized patient selection and innovative surgical techniques.
- 1 January 2025
- Published by Seven Events in ARACÊ
- Vol. 7 (1) , 2683-2696
Open AccessTECHNICAL ANALYSIS OF HARTMANN’S RETROSIGMOIDECTOMY IN THE EMERGENCY CONTEXT OF COMPLICATED DIVERTICULITIS HINCHEY III AND IV
Hartmann’s retrosigmoidectomy is a widely adopted surgical procedure for managing patients with complicated diverticulitis, particularly in Hinchey III and IV stages. These advanced stages are associated with high morbidity and mortality due to purulent or fecal peritonitis, necessitating emergent surgical interventions. This study presents a systematic technical analysis of Hartmann’s procedure in this emergency context, focusing on outcomes such as mortality, morbidity, stoma reversal rates, and long-term complications. A comprehensive search was conducted in PubMed, Embase, Cochrane Library, and Scopus for studies published between 2016 and 2024, using keywords like "Hartmann’s Procedure," "Complicated Diverticulitis," "Hinchey III and IV," and "Emergency Surgery." Of 34 initially identified studies, 10 met the inclusion criteria. Findings reveal that while Hartmann’s procedure remains a vital option for hemodynamically unstable patients, its limitations, such as low stoma reversal rates (43.9%, Facile et al., 2020) and higher long-term complication rates, underscore the need for patient stratification. Comparatively, primary anastomosis demonstrated superior outcomes in selected stable patients, with higher stoma reversal rates (86.9%, Bridoux et al., 2017) and improved quality of life. Advances in laparoscopic approaches have also shown potential in enhancing outcomes for Hartmann’s procedure. Despite its established role, the procedure’s high morbidity and low reversal rates prompt the need for further research into individualized patient selection and innovative surgical techniques.